Frequency distribution of outcome measures and covariates in 1st and 2nd screen sample sets with corresponding geometric mean peak anti-HBs titer (GMT)

Key: Vaccination groups: 1) HB-Vax 3�� 20 ��g im; 2) HB-Vax 1�� 20 ��g im+2�� 2 ��g id; 3) HB-Vax 3�� 2 ��g id; 4) HB-Vax 4�� 10ug im; 5) Recombivax 3�� 5 ��g im; 6) EnergixB 3�� 10 ��g im; 7) Hepacine 4�� (later 3��) 2.5 ��g im [9]. 95%CI: 95% confidence interval.Notes on 1st screen: The ��Kantonkunda+others�� village group includes 33 individuals from other villages or visitors to the region. No individuals in vaccine group 6 were present. The number of individuals with less than 3 doses includes three participants with only two doses of HBV vaccine.Notes on 2nd screen: As there were only four individuals aged >15 years, these were grouped with those aged 10�C15 years. The ��Kantonkunda+others���� village group contains 44 ��others��. There were no individuals from vaccination groups 1 and 2; vaccine groups 3 and 6 were excluded from the analysis as they contained less than five individuals in each. The number of individuals with less than 3 doses included a total of one individual with one dose, and six participants with two doses of HBV vaccine.